HCPCS Level II
J2010
Injection, lincomycin hcl, up to 300 mg
Codes near J2010
These sit next to J2010 in the CMS Level II file. All J codes
- J1990Injection, chlordiazepoxide hcl, up to 100 mg
- J2001Injection, lidocaine hcl for intravenous infusion, 10 mg
- J2002Injection, lidocaine hcl in 5% dextrose, 1 mg
- J2003Injection, lidocaine hydrochloride, 1 mg
- J2004Injection, lidocaine hcl with epinephrine, 1 mg
- J2020Injection, linezolid, 200 mg
- J2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
- J2060Injection, lorazepam, 2 mg
- J2062Loxapine for inhalation, 1 mg
- J2150Injection, mannitol, 25% in 50 ml
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00009-0104-04 | Lincocin | Pfizer Inc | 2 |
| 00009-0107-04 | Lincocin | Pfizer Inc | 10 |
| 00009-0555-01 | Lincocin | Pfizer Inc | 2 |
| 00121-1035-55 | Lincomycin HCl | PAI Holdings, LLC | 100 |
| 00404-9901-10 | Lincomycin | Henry Schein Inc. | 10 |
| 25021-0193-02 | Lincomycin HCl | Sagent Pharmaceuticals | 20 |
| 25021-0193-10 | Lincomycin HCl | Sagent Pharmaceuticals | 100 |
| 39822-0350-02 | Lincocin | XGen Pharmaceuticals DJB, Inc. | 20 |
| 39822-0353-06 | Lincocin | XGen Pharmaceuticals DJB, Inc. | 100 |
| 50090-4533-00 | Lincomycin HCl | A-S Medication Solutions | 10 |
| 72485-0114-01 | Lincomycin | Armas Pharmaceuticals Inc. | 2 |
| 72485-0115-10 | Lincomycin | Armas Pharmaceuticals Inc. | 100 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.